Man Group
AERI

Man Group’s Aerie Pharmaceuticals AERI Stock Holding History

Man Group’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-43,400
Closed -$586K – 2051
2020
Q4 		$586K Sell
43,400
-9,200
-17% -$111K ﹤0.01% 1519
2020
Q3 		$619K Buy
+52,600
New +$641K ﹤0.01% 1495
2019
Q3 		– Sell
-42,183
Closed -$1.25M – 1965
2019
Q2 		$1.25M Buy
+42,183
New +$1.63M ﹤0.01% 1458
2018
Q4 		– Sell
-47,677
Closed -$2.93M – 2178
2018
Q3 		$2.93M Buy
+47,677
New +$3.06M 0.01% 1252

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Man Group's AERI Position: Q1 2021 in Review

Man Group sold out of Aerie Pharmaceuticals (AERI) in Q1 2021, closing a stake of 43,400 shares — an estimated $586K sold.

Man Group first reported a position in AERI in Q3 2018 and held it in 4 quarters. The position peaked at $2.93M in Q3 2018. 158 funds tracked by Wall St. Rank hold AERI as of Q1 2021.

  • Man Group reported no remaining Aerie Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Man Group sold 43,400 Aerie Pharmaceuticals shares in Q1 2021, an estimated $586K.
  • Man Group first reported a position in Aerie Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Man Group's Aerie Pharmaceuticals position peaked at $2.93M in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2021.

Based on Man Group's 13F filing for Q1 2021, filed 17 May 2021.